精神分裂症再接收风险的预测因素:来自沙特阿拉伯队列的见解
Mahmoud A Alharthi1, Rajaa M Al-Raddadi2, Sulhi A Alfakeh3
1Population Health Management, Jeddah First Health Cluster, Jeddah, Saudi Arabia.
Frontiers in psychiatry
|October 2, 2025
概括
沙特阿拉伯的精神分裂症再入院率很高,不充分的后续护理显著增加了风险. 改善退院后的支持对于减少住院治疗至关重要.
科学领域:
- 精神病学是一个精神病学.
- 心理健康研究 心理健康研究
- 公共卫生 公共卫生
背景情况:
- 精神分裂症复诊对患者,家庭和医疗保健系统构成挑战.
- 在沙特阿拉伯,关于精神分裂症再入院预测因素的研究有限.
研究的目的:
- 评估吉达的精神分裂症患者再接收率.
- 确定与再接收风险相关的社会人口因素.
主要方法:
- 在2018年入院的145名精神分裂症患者的回顾性队列研究.
- 分析社会人口统计数据,病史,药物坚持和后续护理.
- 对具有一年再接收率的协会进行检查.
主要成果:
- 一年再接收率为36.6%.
- 关键预测因素包括以前的入院和门诊随访频率.
- 不充分的后续护理显著增加了再接收的概率.
结论:
- 改善住院到门诊护理的转变可以减少精神分裂症的再入院.
- 有针对性的干预措施对于尽量减少沙特阿拉伯的再接收率至关重要.
更多相关视频
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
530
05:52Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
15.4K
相关概念视频
Psychological and Sociocultural Causes of Schizophrenia
470
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
470
Biological Causes of Schizophrenia
501
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
501
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
1.8K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.8K
Schizophrenia
761
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
761
Psychosis: Goals of Pharmacotherapy
474
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
474
